Black Bird Biotech, Inc. (BBBT)
Black Bird Biotech, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Argyle, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $98,405. On trailing twelve-month figures it carries a trailing P/E of -0.02, a net margin of -2009.1%. Its beta of 1.87 implies it has historically moved more than the broad market.
Black Bird Biotech Inc. operates within the biotechnology sector, offering a diverse array of products. A key offering is MiteXstream, a unique plant-derived biopesticide manufactured and distributed by the company, specifically formulated to eradicate spider mites. The company further diversifies its portfolio with a range of consumer goods sold under its Grizzly Creek Naturals brand. These include CBD oils, gummies, and pet treats, as well as CBD-infused personal care items and both gel and spray hand sanitizer products. Beyond these offerings, Black Bird Biotech also engages in the cultivation of industrial hemp, participating in the Montana Hemp pilot program. The entity, headquartered in Flower Mound, Texas, underwent a name change in June 2021, transitioning from its former identity as Digital Development Partners, Inc. to its current Black Bird Biotech, Inc. designation.
Black Bird Biotech, Inc. is most often compared with the following Healthcare names: